BCR/ABL1 plays a key role in development of chronic myelogenous leukemia (CML) and in some cases of Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph1-ALL). This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.